• The document is an intimation of a series of one-on-one Analyst/Investor meetings.
  • The meetings are scheduled for Thursday, November 19, 2026, in Mumbai.
  • The stated purpose is compliance with Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
  • The meetings are scheduled as follows:
  • Malabar Investments: In-person, 11.00 AM – 12.00 PM IST
  • Baroda Mutual Fund: In-person, 12.30 PM – 01.30 PM IST
  • Steinberg: In-person, 02.15 PM – 03.15 PM IST
  • Birla Mutual Fund: In-person, 04.00 PM – 05.00 PM IST
  • Carnelian: In-person, 05:30 PM – 06.30 PM IST
  • A note clarifies that the schedule is subject to changes due to exigencies on the part of the Analysts/Investors.
  • A presentation for the meeting is available at the provided URL: https://d28c6jni2fmamz.cloudfront.net/ECPH1Q2FY27_f8e43c260a.pdf
  • The disclosure will also be made available on the Company's website at www.starhealth.in.
  • The document contains standard compliance language but does not explicitly state whether unpublished price sensitive information (UPSI) will or will not be shared.

Additional Notes Section

  • The document is a formal letter of intimation addressed to the Listing Departments of BSE Limited and the National Stock Exchange of India Limited.
  • It is signed by Jayashree Sethuraman, Company Secretary & Compliance Officer.
  • The document reference number is SHAI/B & S/SE/157/2026-27.
  • No financial data, guidance, or strategic updates were disclosed in this announcement. The provided link points to a presentation deck, the contents of which are not summarized here.